• 1
    Calderón MA, Casale TB, Togias A, Bousquet J, Durham SR, Demoly P. Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J Allergy Clin Immunol 2011;127:3038.
  • 2
    Burks AW, Calderón MA, Casale T, Cox L, Demoly P, Jutel M et al. Update on allergy immunotherapy: American academy of allergy, asthma and immunology/european academy of allergy and clinical immunology/ PRACTALL consensus report. J Allergy Clin Immunol 2013. doi: 10.1016/j.jaci.2013.01.049.
  • 3
    Noon L. Prophylactic inoculation against hay fever. Lancet 1911;1:15721573.
  • 4
    Freeman J. Further observations on the treatment of hay-fever by hypodermic inoculation of pollen vaccine. Lancet 1911;2:814817.
  • 5
    Canonica GW, Baena-Cagnani CE, Bousquet J, Bousquet PJ, Lockey RF, Malling HJ et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 2007;62:317324.
  • 6
    Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998;102:558562.
  • 7
    Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86):8160.
  • 8
    Bousquet PJ, Brozek J, Bachert C, Bieber T, Bonini S, Burney P et al. The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper. Allergy 2009;64:17371745.
  • 9
    Bousquet PJ, Calderón MA, Demoly P, Larenas D, Passalacqua G, Bachert C et al. The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: a Global Allergy and Asthma European Network (GA(2)LEN) article. J Allergy Clin Immunol 2011;127:4956.
  • 10
    Bousquet J, Schünemann HJ, Samolinski B, Demoly P, Baena-Cagnani CE, Bachert C et al. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol. 2012;130:10491062.
  • 11
    Alvarez-Cuesta E, Bousquet J, Canonica GW, Durham SR, Malling HJ, Valovirta EEAACI, Immunotherapy Task Force. Standards for practical allergen-specific immunotherapy. Allergy 2006;61(Suppl 82):120.
  • 12
    Calderon M, Cardona V, Demoly P, EAACI 100 Years of Immunotherapy Experts Panel. One hundred years of allergen immunotherapy European academy of allergy and clinical immunology celebration: review of unanswered questions. Allergy 2012;67:462476.
  • 13
    Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127:S1S55.
  • 14
    Committee for Medicinal Products for Human Use. Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases. CHMP/EWP/18504/2006. London. European Medicines Agency. Pre-authorisation evaluation of medicines for human use. 20 November 2008. Available at Last accessed 20 March 2013
  • 15
    Allergic rhinitis: clinical development programs for drug products. Guidance for Industry. Beltsville, MD, April 2000. US Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Available at Last accessed 20 March 2013.
  • 16
    Guidance for reviewers. Potency limits for standardized dust mite and grass allergen vaccines: a revised protocol. Beltsville, MD, November 2000. US Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Available at Last accessed 20 March 2013.
  • 17
    Zhang L, Götz M, Hofmann S, Greiner J. Immunogenic targets for specific immunotherapy in multiple myeloma. Clin Dev Immunol. 2012;2012:820394.
  • 18
    Esch RE. Specific immunotherapy in the U.S.A.: general concept and recent initiatives. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2003;94:1723.
  • 19
    Bieber T, Simon HU. Allergen-specific immunotherapy: current concepts and future directions. Allergy 2011;66:709712.
  • 20
    Ring J, Gutermuth J. 100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT). Allergy 2011;66:713724.
  • 21
    Johansson SGO, Bieber T, Dahl R, Friedmann PS, Lanier B, Lockey R et al. A revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of World Allergy Organization. J 7Allergy Clin Immunol 2004;113:832836.